Phenylketonuria (PKU) is a genetic disorder caused by mutations affecting the metabolism of phenylalanine, leading to severe neurological effects such as mental retardation and seizures. Diagnosis involves increased serum phenylalanine levels, and treatment typically includes a low-protein diet, while future therapies may involve gene and stem cell treatments. PKU also results in characteristic symptoms like hypopigmentation and a distinctive mousy odor of urine due to metabolite excretion.